Squarepoint’s Tenax Therapeutics TENX Stock Holding History

Squarepoint’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$485K	Buy	+33,334	New	+$426K	﹤0.01%	3451

Other funds holding TENX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Squarepoint's TENX Position: Q2 2026 in Review

Squarepoint opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 33,334 shares worth $485K. The stake represents ﹤0.01% of the portfolio and ranks #3451 among its holdings.

111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

Squarepoint held 33,334 shares of Tenax Therapeutics worth $485K as of Q2 2026.
Tenax Therapeutics was a new Squarepoint position in Q2 2026.
Tenax Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3451 holding.
111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.